GHK-Cu user experiences: what users themselves report

Users’ own accounts, not research. The accounts are self-selected and prove neither that it works nor that it is safe.

This page does not list users’ doses or sellers, and no figure on it is a recommendation. Doses used in studies, with sources: GHK-Cu dosage in studies.

Updated 15 Oct 2026 Data: 3,247 posts and comments read, 743 people Author: An AI model read and classified every account following written instructions

In short

Of 743 people, 369 (50%) said GHK-Cu brought some benefit and 401 (54%) some harm.

We went through 1,747 public Reddit posts and a random sample of comments (1,500); the first-hand experiences of 743 users among them are compiled here. Method: Where the accounts come from and how we read them. Use of AI: AI disclosure.

Where the accounts come from and how we read them

Sources: the Reddit forums r/Peptides (543 accounts), r/Biohackers (236), r/bpc_157 (74), r/Retatrutide (14), r/tretinoin (12), r/Nootropics (5), r/Melanotan2 (5), r/NMN (3), r/glutathione (2), r/TB500 (1) and r/mk677 (1), 14 Oct 2024 to 12 Oct 2026. The posts were retrieved from a public Reddit archive. 4,124 posts matched the search, and 3,000 of them were taken at random. Of those, 1,747 were first-person posts about GHK-Cu, and every one was read. In addition, 9,113 comments met the same criteria in the same period (two years, 13 Oct 2024 to 13 Oct 2026), and a random 1,500 of them were read. The sample was drawn with a fixed seed, so it can be repeated.

Coding: for each account we recorded the route, reported benefits and harms, how strong a harm was, whether and why the person stopped, length of use and other substances used at the same time. We kept accounts that reported some effect, some harm, or no effect. Questions and plans were left out. A harm was recorded when the person reported it during use, even if the cause was uncertain. Several posts by one person count as one person. One person can mention several things, so the shares in the tables do not add up to 100.

Check: an AI model read and classified the posts following written instructions. A second, separate AI run classified a random tenth (175 posts) again without seeing the first classification. The main fields matched: 171/175 (98%). 150 of the comments were re-classified the same way, and the main fields matched: 148/150 (99%). 11 posts looked like marketing and are not in the figures.

Whose accounts these are: routes mentioned: injection 373, on the skin 33, injection and on the skin 18, by mouth 5; the others did not say. The figures describe the writers and are not a recommendation. The products were not verified, so we do not know what people actually took.

Did GHK-Cu help? The overall picture

Of 743 people, 278 (37%) reported benefit only, 91 (12%) both benefit and harm, 310 (42%) harm only and 64 (9%) neither.

Stopping. 81 people (11%) said they stopped or paused: 68 because of harms and 13 because they noticed no effect or for another reason.

Share = people / 743.
Overall picture: benefit, harm or neitherPeopleShare
Benefit only27837%
Both benefit and harm9112%
Harm only31042%
Neither benefit nor harm649%

Posts vs. comments

The figures on this page combine two sets: all 442 people who described their own use in a post, and 301 people found only in comments. 9,113 comments met the criteria, and a random 1,500 of them were read, from the same period as the posts: two years, 13 Oct 2024 to 13 Oct 2026. Because only part of the comments was read, the combined shares are not an average of the whole discussion.

Comments reported benefit only clearly more often, and harms less often, than posts. Benefit only: 30% in posts and 50% in comments (difference +20 percentage points, 95% confidence interval +12 to +27). Some harm: 64% in posts and 39% in comments (difference -25 percentage points, 95% confidence interval -32 to -18).

A possible explanation, which we have not verified: people tend to write their own post when something goes wrong, while replies often say briefly that it worked. Neither group tells how often it really helps or harms, and the difference does not prove that it works.

Share = people / group n; number of people in brackets. Comments = people not already counted from posts. Difference = comments minus posts, from unrounded shares. A difference is clear when its 95% confidence interval does not include zero.
ReportedPosts (n = 442)Comments (n = 301)Difference, points (95% CI)Clear difference?
Benefit only30% (132)50% (149)+20 (+12, +27)Yes
Some harm64% (282)39% (116)-25 (-32, -18)Yes

Most common reported benefits

Of 743 people. 369 (50%) mentioned some benefit; the table lists every benefit reported.

ReportedPeopleShare
Skin quality, firmness or fine lines14319%
Less pain or inflammation628%
Hair growth or thickness608%
Healing of wounds or injuries578%
Energy or wellbeing355%
Skin glow or tone324%
Scars or marks243%
Less acne132%
Under-eye area81%
Other benefit14520%

Share = people / 743.

Most common reported harms

Of 743 people. 401 (54%) mentioned some harm; 47 said explicitly they had none.

ReportedPeopleShare
Injection site pain, redness or lump21229%
Breakouts or purging294%
Fatigue284%
Allergic reaction or hives263%
Mood or anxiety223%
Sleep problems182%
Skin darkening or patches162%
Nausea111%
Dryness or flaking81%
Headache81%
Skin irritation, redness or stinging (topical)51%
Hair shedding41%
Metallic taste10%
Other, rarer harm13718%
Harms mentioned but not named61%

Share = people / 743.

How severe were the harms?

Of the 399 people who described how strong a harm was, 249 (62%) described it as mild, 135 (34%) as clearly bothersome and 15 (4%) as severe. The strength is the writer's own description, not a doctor's assessment.

Share = people / 399.
Strength of the harm as the writer described itPeopleShare
Mild: minor and manageable24962%
Clearly bothersome: several days, sleep or work affected13534%
Severe: emergency visit, hospital or unable to function154%

Harms known from research and regulators: What are the side effects of GHK-Cu?

How long did people use GHK-Cu?

415 of 743 people (56%) said how long they had been using it at the time of writing. Where one person wrote several posts, the longest stated time counts.

Share = people / 415.
Stated length of usePeopleShare
Under a week8721%
1-4 weeks12530%
1-3 months14735%
Over 3 months5613%

Many people post partway through, often in the first days or as soon as harms start, so short times are over-represented. The numbers describe the writers; they do not say how long it should be used.

Other substances at the same time

502 of 743 people (68%) used other substances at the same time. The most common: BPC-157 (318), TB-500 (278) and KPV (145). Then the account cannot tell which substance had the effect.

Injected or applied to the skin?

Of those who said how they used it, 373 described injections, 18 both injections and applying it to the skin, 33 applying it to the skin only and 5 taking it by mouth. The others did not say.

383 people injected it. Of them, 288 (75%) reported some harm and 212 (55%) pain, redness or a lump at the injection site. 128 (33%) reported some benefit.

50 applied it to the skin, and some of them also injected. Of them, 33 (66%) reported some benefit and 19 (38%) some harm. The group is small and mixed with injections, so these figures do not reliably describe creams or serums. Accounts from users of skin creams and serums are compiled separately: user experiences with collagen and skin peptides.

About dosing

We do not repeat the amounts or ways of use people mention, and we give no dosing or how-to instructions. A safe dose is not known. Doses used in studies, with sources: GHK-Cu dosage in studies. Legal status: Is GHK-Cu legal in Finland?

What can be concluded?

The accounts are mostly about injections, and the most common thing reported was an injection-site reaction. They say little about GHK-Cu applied to the skin.

The accounts prove neither that it works nor that it is safe. The writers are self-selected, the product contents are unknown, many used several substances at once, and placebo effects can be large. The research and its evidence levels: GHK-Cu: what the research shows.

Quotes

Short excerpts in the writers’ own words. Writers’ names and links are not shown. We picked quotes from every group: benefit, both benefit and harm, no effect, harms and people who stopped.

Other summaries made with the same method: BPC-157 user experiences, GLOW blend user experiences, KLOW blend user experiences, TB-500 user experiences, KPV user experiences, Melanotan II user experiences, Melanotan 1 user experiences and user experiences with collagen and skin peptides.

Content is general information about research, not medical advice. If you have symptoms, contact a healthcare professional.